Additionally, using another public database, a Kaplan–Meier analysis of breast cancer patients indicated that high NR2F1‐AS1 levels correlated with poor overall survival (OS) and distant metastasis‐free survival (DMFS), even when restricted to ER‐positive cases (Fig 3E‐F). Here, NR2F1 is linked to breast cancer.